People: Mauna Kea Technologies SA (MKEA.PA)

MKEA.PA on Paris Stock Exchange

4.42EUR
11:35am EDT
Change (% chg)

€0.04 (+0.91%)
Prev Close
€4.38
Open
€4.36
Day's High
€4.44
Day's Low
€4.35
Volume
10,003
Avg. Vol
53,030
52-wk High
€11.31
52-wk Low
€4.30

Search Stocks

Brisson, Gilles 

Mr. Gilles Brisson has been Chairman of the Board and Independent Director of Mauna Kea Technologies SA since March 5, 2012. He is Member of the Company's Audit Committee and Remuneration Committee. He has served in various roles during his 20-year tenure at Rhone-Poulenc Rorer, including Senior Vice-President of Corporate Development. He led Aventis’ French pharmaceutical business from 1999 to 2003 as President and Chief Executive Officer. Then he became Senior Vice President of Europe for Aventis and Sanofi aventis. Mr. Brisson has been Chairman of the Supervisory Board of Innate Pharma since 2007 and of Ethypharm since 2009.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks